Company Profiles

driven by the PitchBook Platform

Aerial BioPharma

Description

Provider of narcolepsy treatments. The company operates sleep centers as clinical trial sites for studies of its narcolepsy drug and also develops an early-stage biologic to treat acute and chronic pain.

2011

Founded

PRIVATE

Status

11-50

Employees

Series A

Latest Deal Type

$9.5M

Latest Deal Amount

$19.5M

Total Amount Raised

Description

Provider of narcolepsy treatments. The company operates sleep centers as clinical trial sites for studies of its narcolepsy drug and also develops an early-stage biologic to treat acute and chronic pain.

Website:

www.aerialbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

Aerial Center Executive Park 9001 Aerial Center Parkway, Suite 110 Morrisville, NC 27560United States +1 (919) 460-9500
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Aerial BioPharma's full profile, request a free trial.

Aerial BioPharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Aerial BioPharma Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
3G CapitalPE/BuyoutMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Rex Health VenturesCorporate Venture CapitalMinority000 0000000 0000
3G Capital PE/Buyout
Individual Investor Angel (individual)
Rex Health Ventures Corporate Venture Capital

Aerial BioPharma Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Moise Khayrallah Ph.DChief Executive Officer & Co-Founder
Stephen ButtsPresident, Chief Operating Officer & Co-Founder
Gary Bream Ph.DExecutive Vice President, Drug Development & Co-Founder
Meg Powell Ph.DVice President, Corporate Development
Kenneth Freeman Ph.DSenior Director, Chemistry and Manufacturing
Moise Khayrallah Ph.D Chief Executive Officer & Co-Founder
Stephen Butts President, Chief Operating Officer & Co-Founder
Gary Bream Ph.D Executive Vice President, Drug Development & Co-Founder
Meg Powell Ph.D Vice President, Corporate Development
Kenneth Freeman Ph.D Senior Director, Chemistry and Manufacturing
Request full access to PitchBook